Reviewing Surgery Partners (SGRY) and Its Rivals
Surgery Partners (NASDAQ: SGRY) is one of 15 public companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it contrast to its rivals? We will compare Surgery Partners to related companies based on the strength of its risk, dividends, valuation, profitability, analyst recommendations, institutional ownership and earnings.
Volatility and Risk
Surgery Partners has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500. Comparatively, Surgery Partners’ rivals have a beta of 0.87, suggesting that their average share price is 13% less volatile than the S&P 500.
37.1% of Surgery Partners shares are held by institutional investors. Comparatively, 64.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 7.6% of Surgery Partners shares are held by insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
This table compares Surgery Partners and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Surgery Partners Competitors||4.56%||4.29%||4.73%|
Valuation and Earnings
This table compares Surgery Partners and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||NetIncome||Price/Earnings Ratio|
|Surgery Partners||$1.15 billion||$9.45 million||-17.17|
|Surgery Partners Competitors||$1.06 billion||-$22.56 million||456.00|
Surgery Partners has higher revenue and earnings than its rivals. Surgery Partners is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a breakdown of recent ratings and price targets for Surgery Partners and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Surgery Partners Competitors||57||321||502||9||2.52|
Surgery Partners presently has a consensus price target of $18.00, indicating a potential upside of 127.85%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 11.69%. Given Surgery Partners’ higher possible upside, research analysts plainly believe Surgery Partners is more favorable than its rivals.
Surgery Partners rivals beat Surgery Partners on 9 of the 13 factors compared.
About Surgery Partners
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.